BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

123 related articles for article (PubMed ID: 24228484)

  • 21. [Antiarrhythmic properties of the anticonvulsant drug benzonal].
    Saratikov AS; Fateeva SN; Forshkova VK
    Farmakol Toksikol; 1987; 50(6):42-4. PubMed ID: 3436422
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Antiarrhythmic effect of 4-(3',5'-bis ((n-pyrrolidinyl) methyl)-4'-hydroxyanilino) quinazoline (changrolin) on aconitine-induced arrhythmia in rats (author's transl)].
    Wang ZM; Zhang YF; Ding GS
    Yao Xue Xue Bao; 1979 Jul; 14(7):408-11. PubMed ID: 532636
    [No Abstract]   [Full Text] [Related]  

  • 23. [The relationship between the chemical structure and anti-arrhythmia action of a number of omega-aminoacyl-3-carbalcoxyaminodibenzazepines].
    Gritsenko AN; Lyskovtsev VV; Senova ZP; Skoldinov AP; Stark A; Wunderlich G; Poppe H; Barch R
    Farmakol Toksikol; 1990; 53(3):30-2. PubMed ID: 2387375
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Anti-arrhythmia properties of marcaine].
    Dzhaparidze MM; Berdiaev SIu; Darinskiĭ NV; Senova ZP; Liubushkina TE
    Biull Eksp Biol Med; 1983 Sep; 96(9):64-7. PubMed ID: 6616058
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [The relationship between the chemical structure and the antiarrhythmic action of ethacizine and its analogs].
    Turilova AI; Berdiaev SIu; Grishchenko AN; Senova ZP
    Farmakol Toksikol; 1990; 53(6):20-1. PubMed ID: 2081560
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Hydrochlorides of N-hydroxyalkyl-alpha-piperidine carboxylic arylamides possessing antiarrhythmic activity].
    Kaverina NV; Skoldinov AP; Dzhaparidze MM; Berdiaev SIu; Darinskiĭ NV
    Farmakol Toksikol; 1984; 47(5):25-8. PubMed ID: 6500031
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Comparative study of the activity of anti-arrhythmia agents in calcium chloride-induced arrhythmia in mice].
    Gorbunova VV; Gorbunov NP
    Farmakol Toksikol; 1983; 46(3):48-50. PubMed ID: 6861988
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Anti-arrhythmia activity of fusaric acid N,N-diethylaminoethylamide in experimental arrhythmia models in comparison with novocainamide].
    Savina MD; Kudrin AN
    Farmakol Toksikol; 1982; 45(2):63-5. PubMed ID: 7075754
    [No Abstract]   [Full Text] [Related]  

  • 29. Derivatives of 2-mercaptobenzenesulphonamide. XVIII. Syntheses and cardiovascular effects of some S- and S,N-substituted 4-chloro-2-mercapto-5-methyl-N-(5-amino-1,2,4-triazol-3-yl) benzenesulphonamide derivatives.
    Brzozowski Z; Pomarnacka E; Oledzka K; Filczewski M
    Acta Pol Pharm; 1995; 52(3):223-30. PubMed ID: 8960253
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Antiarrhythmic properties of a cannabinoid (CB) receptor agonist].
    Maslov LN; Lishmanov IuB; Maĭsmekulova LA; Mechoulam P
    Eksp Klin Farmakol; 2001; 64(3):37-40. PubMed ID: 11558437
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Pharmacological study of quaternary trimecaine derivatives].
    Gendenshteĭn EI; Tsybusov AP; Zhukauskaĭte LN; Stankevichius AP; Bukauskas FF
    Farmakol Toksikol; 1983; 46(4):36-40. PubMed ID: 6617835
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Comparative study of the antiarrhythmic activity of L-, D-and DL-stereoisomers of potassium magnesium aspartate].
    Spasov AA; Iezhitsa IN; Zhuravleva NV; Gurova NA; Sinolitskiĭ MK; Voronin SP
    Eksp Klin Farmakol; 2007; 70(1):17-21. PubMed ID: 17402586
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Discovery of a class of potent gap-junction modifiers as novel antiarrhythmic agents.
    Piatnitski Chekler EL; Butera JA; Di L; Swillo RE; Morgan GA; Rossman EI; Huselton C; Larsen BD; Hennan JK
    Bioorg Med Chem Lett; 2009 Aug; 19(16):4551-4. PubMed ID: 19616941
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Local anesthetic and antiarrhythmic effect of some imidazolidin-2-one derivatives.
    Librowski T; Filipek B; Czarnecki R
    Acta Pol Pharm; 2000; 57(5):391-6. PubMed ID: 11126032
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Antiarrhythmic activity of taurhythman.
    Sapronov NS; Gavrovskaya LK; Krylova IB; Evdokimova NR
    Bull Exp Biol Med; 2005 Nov; 140(5):529-31. PubMed ID: 16758616
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Antiarrhythmic action of 3-carbethoxyamino-5-dimethylaminoacetyl-iminodibenzyl hydrochloride (Bonnecor, AWD 19-166, GS -15) on experimental arrhythmia induced by aconitin, ouabain, calcium chloride and barium chloride].
    Femmer K; Poppe H; Heer S; Bartsch R
    Pharmazie; 1985 Dec; 40(12):836-40. PubMed ID: 3841597
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [The first original Russian class-III antiarrhythmic nibentan].
    Glushkov RG; Golitsyn SP; Dorodnikova EV; Maĭkov EB; Mashkovskiĭ MD; Merkulova IN; Rozenshtraukh LV; Ruda MIa; Skachilova SIa; Chazov EI; Iuzhakov SD
    Vestn Ross Akad Med Nauk; 1998; (11):38-41. PubMed ID: 9889704
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Cardiac effects of lappaconitine and N-deacetyllappaconitine, two diterpenoid alkaloids from plants of the Aconitum and Delphinium species.
    Heubach JF; Schüle A
    Planta Med; 1998 Feb; 64(1):22-6. PubMed ID: 9491764
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Propranolol analog with the natural monoterpene structure as a potent antiarrhythmic drug.
    Librowski T; Filipek B; Czarnecki R; Beresewicz A; Karwatowska-Prokopczuk E
    Acta Pol Pharm; 1998; 55(3):243-7. PubMed ID: 9735705
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [The anti-arrhythmic activity of quinuclidine derivatives].
    Svistov AS; Skorobogatov VI
    Eksp Klin Farmakol; 1994; 57(5):20-1. PubMed ID: 7696896
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.